REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
01/05/2026
Back to search
Official data from USPTO
INNOVENT
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
32
Latest update
01/06/2026
Trademark type
Combined
Nice classes
5
Filing date
11/01/2018
Registration date
01/05/2021
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
01/05/2021
Last transaction
01/06/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
Drawing code
3
Owner type
99
Owner location
Suzhou City, CN
Examiner
PATE,TARA J
Law office
S10
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of the word "INNOVENT"; the "O" in "INNOVENT" is comprised of two symmetrical arcs, with Chinese characters beneath the word "INNOVENT".
Holders and representatives
Holders
Innovent Biologics (Suzhou) Co., Ltd.
Representatives
Anessa Owen Kramer HONIGMAN LLP
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Medicines for human purposesused for treating tumorophthalmology diseasescardiovascular diseasesimmune diseasesmetabolic diseasesblood diseasesdiabetesendocrine system diseasesreproductive system diseasesrespiratory system diseasescentral and peripheral nervous system diseasescancerantivirals; pharmaceutical preparationsused for treating tumorophthalmology diseasescardiovascular diseasesimmune diseasesmetabolic diseasesblood diseasesdiabetesendocrine system diseasesreproductive system diseasesrespiratory system diseasescentral and peripheral nervous system diseasescancerantivirals; drugs in the nature of pharmaceutical preparations for medical purposesused for treating tumorophthalmology diseasescardiovascular diseasesimmune diseasesmetabolic diseasesblood diseasesdiabetesendocrine system diseasesreproductive system diseasesrespiratory system diseasescentral and peripheral nervous system diseasescancerantivirals; chemico-pharmaceutical preparationsused for treating tumorophthalmology diseasescardiovascular diseasesimmune diseasesmetabolic diseasesblood diseasesdiabetesendocrine system diseasesreproductive system diseasesrespiratory system diseasescentral and peripheral nervous system diseasescancerantivirals; chemical preparations for medical purposesused for treating tumorophthalmology diseasescardiovascular diseasesimmune diseasesmetabolic diseasesblood diseasesdiabetesendocrine system diseasesreproductive system diseasesrespiratory system diseasescentral and peripheral nervous system diseasescancerantivirals; injectable preparations for medical purposesused for treating tumorophthalmology diseasescardiovascular diseasesimmune diseasesmetabolic diseasesblood diseasesdiabetesendocrine system diseasesreproductive system diseasesrespiratory system diseasescentral and peripheral nervous system diseasescancerantivirals; biological preparations for medical purposesused for treating tumorophthalmology diseasescardiovascular diseasesimmune diseasesmetabolic diseasesblood diseasesdiabetesendocrine system diseasesreproductive system diseasesrespiratory system diseasescentral and peripheral nervous system diseasescancerantivirals; vaccines; diagnostic preparations for medical purposes; dietetic foods adapted for medical use; biological tissue cultures for medical purposes; nutraceutical preparations for use as a dietary supplement for therapeutic or medical purposes
Publications
History of USPTO decisions and trademark events.
32 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
01/05/2021
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
10/20/2020
PUBO
PUBLISHED FOR OPPOSITION
10/20/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
09/30/2020
ADBS
1(B) BASIS DELETED; NEW BASIS REQUESTED
09/17/2020
IUCN
NOTICE OF ALLOWANCE CANCELLED
09/17/2020
ATRQ
ATTORNEY REVIEW/DECISION ON AMENDMENT REQUIRED
09/11/2020
PCBG
PETITION TO DIRECTOR - CHANGE BASIS - GRANTED
09/11/2020
APET
ASSIGNED TO PETITION STAFF
09/09/2020
TPAD
TEAS PETITION TO AMEND BASIS RECEIVED
07/24/2020
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
06/16/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
04/21/2020
PUBO
PUBLISHED FOR OPPOSITION
04/21/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
04/01/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
03/19/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
03/13/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/12/2020
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
03/12/2020
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
02/26/2020
GNFR
FINAL REFUSAL E-MAILED
02/26/2020
CNFR
FINAL REFUSAL WRITTEN
02/26/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
08/24/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
08/23/2019
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
08/23/2019
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
03/11/2019
GNRT
NON-FINAL ACTION E-MAILED
03/11/2019
CNRT
NON-FINAL ACTION WRITTEN
03/11/2019
DOCK
ASSIGNED TO EXAMINER
02/07/2019
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
11/17/2018
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
11/16/2018
NWAP
NEW APPLICATION ENTERED
11/05/2018
Continuous trademark protection
Get notified about every new filing that threatens INNOVENT or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.